DelveInsight's Triple-Negative Breast Cancer Market Insights report includes a comprehensive understanding of current ...

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by i ...

The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor ...

The company’s leaders should have realized that they faced a strategic choice: Either align its growth strategy with its core value proposition—which would have meant slower growth, less ...

Astronomer, the company tied to a viral video from a Coldplay concert, says it's launched a "formal investigation" into the matter.

Author and CEO of Euforia Sneakers, Dylan Ratigan, joins Morning Joe to discuss Trump's plans to tell over 150 countries they will face tariffs.

BACKGROUND: APRIL, a randomized placebo-controlled phase Ib/IIa trial, showed safety and reduced mortality and disability at 90 days of ApTOLL 0.2 mg/kg in combination with endovascular treatment in ...

Low serum albumin levels indicate frailty and are strong predictors of poor prognosis after mitral transcatheter edge‐to‐edge repair (M‐TEER); however, albumin levels are expected to improve in ...